Department of Food Science and Technology, National Pingtung University of Science and Technology, Pingtung, Taiwan.
Int Immunopharmacol. 2013 Jan;15(1):106-13. doi: 10.1016/j.intimp.2012.10.017. Epub 2012 Nov 8.
The hepatoprotective effects of an aqueous extract formula (AEF) derived from Artemisia capillaris, Lonicera japonica and Silybum marianum (ratio 1:1:1) were evaluated by its antioxidant properties and its attenuation of carbon tetrachloride (CCl(4))-induced liver damage in rats. The antioxidant analyses revealed that the AEF showed higher 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical and superoxide anion radical scavenging activities as well as ferric reducing antioxidant potential (FRAP) and Trolox equivalent antioxidant capacity (TEAC) compared with the individual herbs, suggesting a synergism in antioxidation between the three herbs. The animal experiments showed that the CCl(4) treatment increased serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, but decreased triglyceride (TG) and glutathione (GSH) levels as well as glutathione peroxidase (GPx), superoxide dismutase (SOD) and catalase (CAT) activities. However, AEF administration can successfully lower serum ALT and AST activities, restore the GSH level, ameliorate or restore GPx and CAT activities as well as improve SOD action depending on AEF dosage. Histological examination of liver showed that CCl(4) increased the extent of bile duct proliferation, necrosis, fibrosis and fatty vacuolation throughout the liver, but AEF can improve bile duct proliferation, vacuolation and fibrosis, and restore necrosis. The present study demonstrated the hepatoprotective potential of AEF as an alternative to the traditional silymarin.
用来自青蒿、金银花和水飞蓟(比例为 1:1:1)的水提物配方(AEF)的抗氧化特性及其对四氯化碳(CCl(4))诱导的大鼠肝损伤的抑制作用来评价其肝保护作用。抗氧化分析表明,AEF 表现出比单个草药更高的 1,1-二苯基-2-苦基肼(DPPH)自由基和超氧阴离子自由基清除活性以及铁还原抗氧化能力(FRAP)和 Trolox 等效抗氧化能力(TEAC),表明三种草药之间存在抗氧化协同作用。动物实验表明,CCl(4)处理增加了血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)活性,但降低了甘油三酯(TG)和谷胱甘肽(GSH)水平以及谷胱甘肽过氧化物酶(GPx)、超氧化物歧化酶(SOD)和过氧化氢酶(CAT)活性。然而,AEF 给药可以成功降低血清 ALT 和 AST 活性,恢复 GSH 水平,改善或恢复 GPx 和 CAT 活性,并根据 AEF 剂量提高 SOD 作用。肝脏组织学检查表明,CCl(4)增加了胆管增生、坏死、纤维化和整个肝脏的脂肪空泡化的程度,但 AEF 可以改善胆管增生、空泡化和纤维化,并恢复坏死。本研究证明了 AEF 作为传统水飞蓟素的替代品的肝保护潜力。